Liver Diseases  >>  dasatinib  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
dasatinib / Generic mfg.
NCT00382668: A Study of Dasatinib to See How Liver Impaired and Healthy Subjects Process and React to the Study Drug

Completed
N/A
40
US
Dasatinib, Sprycel
Bristol-Myers Squibb
Liver Diseases
08/07
08/07

Download Options